Naotake Hashimoto

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects

Saori Miyazawa-Hoshimoto, Kazuo Takahashi, Hideaki Bujo et al. · Diabetologia · 2003 · 252 citations · Full text

Obesity, Metabolic Syndrome, Metabolic Disorder +11

Bisphenol A affects glucose transport in mouse 3T3‐F442A adipocytes

Kenichi Sakurai, Michiru Kawazuma, Tetsuya Adachi et al. · British Journal of Pharmacology · 2004 · 157 citations · Full text

Human Diabetes Associated with a Deletion of the Tyrosine Kinase Domain of the Insulin Receptor

Masato Taira, Masanori Taira, Naotake Hashimoto et al. · Science · 1989 · 131 citations

Insulin Resistance, Metabolic Syndrome, Insulin Signaling +15

Clinical, Autoimmune, and Genetic Characteristics of Adult-Onset Diabetic Patients With GAD Autoantibodies in Japan (Ehime Study)

Haruyo Takeda, Eiji Kawasaki, Ikki Shimizu et al. · Diabetes Care · 2002 · 125 citations · Full text